ImmuPharma plc (AIM:IMM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
3.700
-0.105 (-2.76%)
Oct 15, 2026, 4:35 PM GMT

ImmuPharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
233157617
Market Cap Growth
-55.75%521.13%-27.71%13.16%-62.85%-50.56%
Enterprise Value
223147613
Last Close Price
0.040.060.010.020.020.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-48.0448.0448.0448.0448.04
PS Ratio
-----139.54
PB Ratio
12.7045.38-9.246.572.433.74
P/TBV Ratio
12.7045.38-6.852.503.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----109.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.38-1.970.44-0.20-0.26-0.37
Net Debt / EBITDA Ratio
0.290.540.110.070.230.33
Net Debt / FCF Ratio
0.380.570.130.150.270.34
Asset Turnover
-----0.01
Quick Ratio
0.781.460.440.541.391.76
Current Ratio
1.341.520.580.811.612.11
Return on Equity (ROE)
-432.82%-2510.61%-967.41%-163.24%-109.77%-116.20%
Return on Assets (ROA)
-63.37%-110.91%-76.76%-57.18%-37.97%-38.13%
Return on Capital Employed (ROCE)
-130.20%-368.90%418.40%-290.00%-120.00%-116.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.20%-5.80%-49.49%-42.09%-62.07%-49.49%
FCF Yield
-8.00%-7.62%-35.29%-19.65%-39.99%-29.57%
Buyback Yield / Dilution
-18.34%-17.81%-15.04%-19.51%-20.60%-25.47%